Vagus Nerve Emerges as Promising Medical Frontier

New review highlights wide-ranging potential of vagus nerve stimulation across diseases, but experts caution about unproven consumer devices.

Apr. 2, 2026 at 10:34am

Got story updates? Submit your updates here. ›

A sweeping new review of over 660 studies suggests that modulating the vagus nerve, the longest cranial nerve, may influence systems throughout the body and hold promise for treating a wide range of conditions. However, experts note the quality of evidence varies widely, especially for consumer devices that claim to 'activate' the vagus nerve without rigorous testing.

Why it matters

The vagus nerve serves as a central communication highway between the brain and body, governing key reflexes and physiological processes. Emerging research indicates that precisely stimulating the vagus nerve could have far-reaching therapeutic effects, from reducing inflammation to supporting neural plasticity. Understanding the full potential of vagus nerve modulation could lead to new treatments for conditions as diverse as epilepsy, depression, and autoimmune disorders.

The details

The review, published in Comprehensive Physiology, points to potential vagus nerve-based treatments across neurologic, psychiatric, inflammatory, autoimmune, cardiovascular, respiratory, gastrointestinal, metabolic, and renal disorders. Vagus nerve stimulation works by delivering electrical impulses at specific frequencies, often 20 Hz, which can influence neurotransmitters, metabolic regulation, and inflammatory pathways. However, the quality of evidence varies widely, especially for transcutaneous devices that face lower regulatory standards compared to implantable vagus nerve stimulators approved by the FDA.

  • The review paper was published on April 2, 2026.

The players

Troy (Yifeng) Bu

An affiliate at the UC San Diego Qualcomm Institute and director of design engineering for InflammaSense, a company developing a patch to record vagus nerve signaling.

Imanuel Lerman

A physician with UC San Diego Health specializing in pain management and the founder of InflammaSense.

Michael Kilgard

A professor of neuroscience at UT Dallas and director of the Texas Biomedical Device Center.

InflammaSense

A company developing a patch to record vagus nerve signaling.

MicroTransponder Inc. (now Mobia Medical)

A company that markets vagus nerve stimulation therapy for stroke.

Got photos? Submit your photos here. ›

What they’re saying

“Until now, there was no comprehensive review that synthesized the mechanisms and evidence across all of these diseases in one place.”

— Troy (Yifeng) Bu, Affiliate at the UC San Diego Qualcommon Institute and director of design engineering for InflammaSense

“We're hardwired with vagus nerve input to the brain and every organ.”

— Imanuel Lerman, Physician with UC San Diego Health specializing in pain management and founder of InflammaSense

“The same pathways that modulate inflammation are also expressed in the brain. So you can directly impact inflammatory processes within the central nervous system.”

— Imanuel Lerman, Physician with UC San Diego Health specializing in pain management and founder of InflammaSense

“You don't actually have to show it does anything in a double-blind placebo-controlled trial. None of the studies that use transcutaneous activation are held to that standard.”

— Michael Kilgard, Professor of neuroscience at UT Dallas and director of the Texas Biomedical Device Center

“Every heartbeat activates the vagus nerve. Being alive activates the vagus nerve.”

— Michael Kilgard, Professor of neuroscience at UT Dallas and director of the Texas Biomedical Device Center

What’s next

Researchers are continuing to explore new applications for vagus nerve stimulation, particularly for conditions involving inflammation and brain plasticity, such as multiple sclerosis, autism, and post-traumatic stress disorder. The future may hold 'closed-loop' devices that can dynamically adjust stimulation based on a patient's unique physiology.

The takeaway

While vagus nerve stimulation shows promise across a wide range of diseases, experts caution that the quality of evidence varies significantly, especially for consumer devices that claim to activate the vagus nerve without rigorous testing. As the field advances, stronger evidence and more sophisticated technology will be needed to fully realize the therapeutic potential of precisely modulating this crucial communication highway between the brain and body.